A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia

201784 citationsJournal Articlegold Open Access

Authors

ClinicalTrial.gov, NCT01340976.

Good health and well-being

Published in: Journal of Hematology & Oncology

Volume 10, Issue 1, pp. 73-73

Field-Weighted Citation Impact: 4.31